Vigabatrin-Induced Visual Field Defects
A drug surveillance database at Hoechst Marion Roussel, manufacturers of vigabatrin, identified 92 cases of symptomatic visual field defects associated with vigabatrin (usually as add-on therapy) between 1990 and 1997.
Saved in:
| Main Author: | J Gordon Millichap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1998-02-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Test for Vigabatrin-Induced Field Defects in Children
by: J Gordon Millichap
Published: (2002-05-01) -
Vigabatrin vs Carbamazepine in Partial Seizures
by: J Gordon Millichap
Published: (1999-05-01) -
Vigabatrin-Associated Visual Field Defects
by: J Gordon Millichap
Published: (2001-12-01) -
Adrenocorticotropic hormone combined with vigabatrin as a second-line therapy for West syndrome
by: Luciana de Paula Souza, et al.
Published: (2025-08-01) -
Combination Therapy With Vigabatrin and Prednisolone Versus Vigabatrin Alone for Infantile Spasms
by: Rachata Boonkrongsak, et al.
Published: (2025-05-01)